GF Fund Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
Other funds holding PTGX
GF Fund Management's PTGX Position: Q3 2026 in Review
GF Fund Management reduced its Protagonist Therapeutics (PTGX) stake by 6.4% in Q3 2026, selling an estimated $12.4K and leaving 1,266 shares worth $178K. The position accounts for ﹤0.01% of the portfolio, ranked #286.
GF Fund Management first reported a position in PTGX in Q4 2024 and has held it in 8 quarters since. 380 funds tracked by Wall St. Rank hold PTGX as of Q3 2026.
- GF Fund Management held 1,266 shares of Protagonist Therapeutics worth $178K as of Q3 2026.
- GF Fund Management sold 87 Protagonist Therapeutics shares in Q3 2026, an estimated $12.4K.
- Protagonist Therapeutics made up ﹤0.01% of GF Fund Management's portfolio in Q3 2026, its #286 holding.
- GF Fund Management first reported a position in Protagonist Therapeutics in Q4 2024 and has held it in 8 quarters since.
- 380 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q3 2026.
Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.